To help delineate the contributions to analgesia evoked by central and spinal opiate receptors, pethidine was administered intravenously to dogs by bolus followed by infusion. Plasma and cerebrospinal fluid were sampled and assayed for pethidine. Cerebrospinal fluid concentrations followed a similar time course to plasma but with lower concentrations. The average cerebrospinal fluid:plasma ratio was 0.4 and resembled the fraction of unbound pethidine in plasma. It was concluded that cerebrospinal fluid concentrations after intravenous administration were so low that spinal action would be unlikely.
Recent reports describing the efficacy of epidurally and intrathecally administered opiates in providing analgesia l -4 have led to questions regarding their mode of action. While the consensus of opinion suggests that it is the result of direct combination of opiate with receptors located in the substantia gelatinosa of the spinal cord,5 this view is based on circumstantial evidence only. Such evidence includes the clinical observation that high cerebrospinal (CSF) concentrations of pethidine occur after epidural administration of this drug in man. The time course of analgesia appears to be related more to the concentrations in CSF than in blood and poor analgesia is obtained when CSF concentrations are low. 6 The relative contributions of spinal and central opiate receptor occupancy are difficult to assess since epidural doses of pethidine which provide analgesia in patients after surgery also generate blood concentrations (and presumably brain concentrations) similar to those observed after intramuscular injections. 7 To assist in resolving the issue of blood versus CSF-borne opiate concentrations, we measured the simultaneous plasma and CSF concentrations of pethidine following intravenous administration in the dog.
MATERIALS AND METHODS Male mongrel dogs weighing 15 ± 1 kg (n = 3) were prepared for study of blood and CSF dynamics according to the method of Pavlin and Hornbein 8 in which animals were anaesthetised and paralysed and maintained normotensive with intravenous fluids. Lumbar CSF and arterial plasma, obtained at regular intervals, were analysed for pethidine (base) concentrations by gas liquid chromatography. 9 Resolution of this method was approximately ± 5070 and sensitivity was approximately 0.05 mg/I. Pethidine HCI was administered as a bolus (100 mg) at zero time followed by a continuous infusion (0.8 mg/min) from 60-300 minutes. A biexponential equation was fitted to each set of pethidine concentration-time data by an iterative non-linear least squares technique. From the constants for the plasma data, the components of a twocompartment open model were derivedY-13 This analysis was performed to frame the results in comparison to man. Aliquots of residual plasma were pooled and spiked with pethidine to obtain a range of concentrations. The fraction of pethidine unbound to plasma proteins was determined by ultrafiltration. ll 
RESULTS
Plasma concentration-time data are shown in Figure 1 . The parameters of the two compartment open model derived from these data ( Table 1) indicate that a two-to-threefold variability existed between animals in pharmacokinetic behaviour towards pethidine. This variability is not inconsistent with variability known to occur in man. Nevertheless, in absolute terms, the dog does provide a reasonable model for man. However, it should be recognised that while apparent distribution volumes (per kg body weight) were similar to man,13 total body clearance (per kg body weight) was several times that in man. As in man, both the high clearance and large apparent distribution volumes served to Although sampled less frequently than plasma, it was obvious (Figure 1) that CSF concentrations followed a similar time course to plasma concentrations but with lower concentrations. The CSF:plasma concentration ratio determined for all samples in each dog (1, 2 and 3) was respectively (mean ± S.D.) 0.44 ± 0.24,0.45 ± 0.22 and 0.23 ± 0.16. This ratio was not systematically dependent on plasma concentrations but lowest values were measured soon after commencing the infusion and implied that a lag phase occurred. Also, as shown in Figure 1 , the biexponential curve fitted the data poorly during this time.
The fraction unbound to plasma proteins was not dependent on the total pethidine plasma concentrations (single determination) over the range 0.6-3.2 mg/I. At total plasma pethidine concentrations of 0.63, 1.20, 1.70, 2.4 and 3.2 mg/l, the unbound fractions were respectively 0.46, 0.32, 0.45, 0.34 and 0.50. The mean value, 0.41, was similar to plasma binding in man l3 and to the ratio of CSF:plasma concentrations suggesting that CSF does represent an ultrafiltrate of plasma as far as pethidine is concerned.
DISCUSSION
Although it was carried out only in three animals and inter-animal pharmacokinetic Anaesthesia and Intensive Care, Vol. IX, No. 3, August, 1981 variability was apparent, the present study provides an unequivocal answer to the question of CSF-borne concentrations of pethidine following intravenous administration. It would appear that CSF concentrations after intravenous administration are too low to provide analgesia at. the spinal level. CSF concentrations exceeding 10 mg/l (and a CSF:blood concentration ratio > 20) were associated with complete analgesia in post surgical patients but lower CSF concentrations (and CSF:blood ratios) were associated with incomplete analgesia after epidural injections of pethidine. 6 Analgesia was not assessed in the present study but the pethidine blood concentration range examined encompassed the range encountered clinically.lI o 13 The clinical relevance of these data is that epidural injection of pethidine generates blood concentrations which may augment the spinal effects by central action. However, it is unlikely that intravenously administered pethidine will generate CSF concentrations sufficiently high to contribute to a spinal action.
